Netherlands· NL-6b653523b3d9

Azaron, crème 20 mg/g

A tripelennamine product containing tripelennaminehydrochloride, registered in Netherlands by Omega Pharma Nederland B.V.. The same ATC class is registered in 4 of our 19 countries.

ATC D04AA04

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about tripelennaminehydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Tripelennamine is registered in 4 of 19 countries.

Countries holding a registration under ATC D04AA04 (tripelennamine), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
2 of them publish a price we can compare per daily dose

Search tripelennamine products by name

Tripelennamine · ATC D04AA04

4 / 19 countries

Finlandprice
Germany
Netherlands
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: TRIPELENNAMINEHYDROCHLORIDE
Manufacturer: Omega Pharma Nederland B.V.
Country: Netherlands (NL)
ATC code: D04AA04
ATC class: Tripelennamine
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
00091

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tripelennamine in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tripelennamine products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

Germany · Azaron
Spain · Relepost
Finland · Etono

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/1850d747-92c6-4064-b6b4-82159e540301
GET /v1/drugs/1850d747-92c6-4064-b6b4-82159e540301?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Crème",
  "route": "Cutaan gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h00091_smpc.pdf",
  "strength": null,
  "atc_label": "Tripelennamine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg00091",
  "excipients": [
    "CETOSTEARYLALCOHOL",
    "DINATRIUMEDETAAT 2-WATER",
    "POLYSORBAAT, Type onbekend",
    "PROPYLEENGLYCOL (E 1520)",
    "VASELINE, WIT",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "TRIPELENNAMINEHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h00091.pdf",
  "authorised_at": "1973/05/16",
  "procedure_number": null,
  "dispensing_status": "Algemene verkoop [conform voorwaarden CBG AV-lijst d.d. 6 september 2007]",
  "registration_number": "00091",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about tripelennamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console